Known targets — ChEMBL curated mechanism
CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1
The experimentally established mechanism targets of Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.79 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.33 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lactic Acid SCHEMBL9312897 | 0.97 | TP53 (0.73) | TP53TSHRSLC7A5MAPTRNPEP | |
| Lactic Acid SCHEMBL28864462 | 0.97 | TP53 (0.73) | TP53TSHRSLC7A5MAPTRNPEP | |
| Lactic Acid SCHEMBL28099744 | 0.93 | — | — | |
| Lactic Acid SCHEMBL5825768 | 0.93 | — | — | |
| Lactic Acid SCHEMBL5931031 | 0.89 | — | — | |
| Lactic Acid SCHEMBL9066423 | 0.89 | TP53 (1.00) | TP53TSHRSLC7A5OR51E2 | |
| D-Lactic Acid SCHEMBL14947 | 0.89 | — | — | |
| L-Lactic Acid SCHEMBL16958 | 0.89 | — | — | |
| Lactic Acid SCHEMBL9066424 | 0.89 | — | — | |
| L-Lactic Acid SCHEMBL13165963 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 229 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110585860-A | Low-energy-consumption regenerated absorbent and method for absorbing sulfur dioxide in flue gas by using same | 太原师范学院 | 2019-12-20 | — | — | CN | claimed |
| US-20120004268-A1 | INSECTICIDAL COMPOSITIONS COMPRISING CYCLIC CARBONYLAMIDINES | BAYER CROPSCIENCE AG (DE) | 2012-01-05 | — | — | US | claimed |
| US-6277799-B1 | AQUEOUS MIXTURE OF SALT OF HYDROXYCARBOXYLIC ACID AND SURFACTANTS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2001-08-21 | — | — | US | claimed |
| JP-1214007-A | — | — | None | — | — | JP | disclosed |
| US-12594700-B2 | Coatings from polyisocyanurate coatings (rim) and their use in injection molding processes | COVESTRO DEUTSCHLAND AG (DE) | 2026-04-07 | — | — | US | disclosed |
| US-20250388778-A1 | POLYISOCYANATE MIXTURE | COVESTRO DEUTSCHLAND AG (DE) | 2025-12-25 | — | — | US | disclosed |
| US-12492281-B2 | Polyisocyanurate materials as electrical potting compounds | COVESTRO DEUTSCHLAND AG (DE) | 2025-12-09 | — | — | US | disclosed |
| EP-4551634-A1 | POLYISOCYANATE MIXTURE | Covestro Deutschland AG (DE) | 2025-05-14 | — | — | EP | disclosed |
| EP-3688050-B1 | TWO-COMPONENT SYSTEM FOR ELASTIC COATINGS | COVESTRO DEUTSCHLAND AG (DE) | 2025-03-26 | — | — | EP | disclosed |
| US-12247144-B2 | Anhydrously curing polyisocyanate-based adhesives | COVESTRO DEUTSCHLAND AG (DE) | 2025-03-11 | — | — | US | disclosed |
| CN-113631545-B | Polyisocyanurate materials as electrical potting compounds | 科思创德国股份有限公司 | 2025-01-07 | — | — | CN | disclosed |
| EP-1211563-A1 | Resist stripper | Tosoh Corporation (JP) | 2002-06-05 | — | — | EP | disclosed |
| US-6277799-B1 | AQUEOUS MIXTURE OF SALT OF HYDROXYCARBOXYLIC ACID AND SURFACTANTS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2001-08-21 | — | — | US | disclosed |
| CN-1274433-A | Radiation-sensitive compsn. of chemical amplification type containing onium salt type photosensitive acid generating agent | CLARIANT INT LTD (CH) | 2000-11-22 | — | — | CN | disclosed |
| US-5371001-A | Transesterification in the presence of carboxy-esterases or carboxyamidases | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-12-06 | — | — | US | disclosed |
| US-5326887-A | Reacting ester of alpha hydroxy acid oligomer over fixed bed catalyst | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-07-05 | — | — | US | disclosed |
| US-5254718-A | Using enzyme catalyst; simplified separation, purification | E. I. DU PONT DE NEMOURS & COMPANY (US) | 1993-10-19 | — | — | US | disclosed |
| WO-1992015572-A1 | PROCESS FOR THE PREPARATION OF 1,4-DIOXANE-2,5-DIONES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-09-17 | — | — | WO | disclosed |
| WO-1992015547-A1 | ESTERS OF UNSYMMETRICALLY 2-SUBSTITUTED GLYCOLIC ACID DIMERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-09-17 | — | — | WO | disclosed |
| JP-H01214007-A | ELECTROLYTE FOR DRIVING ELECTROLYTIC CAPACITOR | TOYAMA YAKUHIN KOGYO KK | 1989-08-28 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388778-A1 | POLYISOCYANATE MIXTURE | IPO11, IPO5, ALKBH1 | TP53 2565/4885TSHR 4166/4885SLC7A5 1462/4885 |
| US-12594700-B2 | Coatings from polyisocyanurate coatings (rim) and their use in injection molding processes | TST, C9, ESD | TP53 4587/4885TSHR 3835/4885SLC7A5 1504/4885 |
| US-20120004268-A1 | INSECTICIDAL COMPOSITIONS COMPRISING CYCLIC CARBONYLAMIDINES | DDT, PRMT9, PNISR | TP53 4746/4885TSHR 2612/4885SLC7A5 805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.